Incidence and risk factors for psoriasis in the general population

Archives of Dermatology

Volumn 143, Issue 12, 2007, Pages 1559-1565

  Huerta, Consuelo ^a   Rivero, Elena ^b   García Rodríguez, Luis A ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; RANDOM SAMPLE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEX; SKIN DISEASE; SKIN INFECTION; SMOKING; STRESS; TIME SERIES ANALYSIS; VALIDATION PROCESS;

EID: 37249032802     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.12.1559     Document Type: Article

References (44)

1. Braathen LR, Botten G, Bjerkedal T. Prevalence of psoriasis in Norway. Acta Derm Venereol Suppl (Stockh). 1989;142:5-8.
2. Braathen LR, Botten G, Bjerkedal T. Psoriatics in Norway: a questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl (Stockh). 1989;142:9-12.
3. Barisić-Drusko V, Paljan D, Kansky A, Vujasinovic S. Prevalence of psoriasis in Croatia. Acta Derm Venereol Suppl (Stockh). 1989;146:178-179.
4. Brandrup F, Green A. The prevalence of psoriasis in Denmark. Acta Derm Venereol. 1981;61(4):344-346.
5. Lomholt G. Psoriasis in the Faroe Islands. Acta Derm Venereol. 1954;34(1-2):92.
6. Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol. 1996;135(4):533-537.
7. Kavli G, Stenvold SE, Vandbakk Ø. Low prevalence of psoriasis in Norwegian Lapps. Acta Derm Venereol. 1985;65(3):262-263.
8. Falk ES, Vandbakk Ø. Prevalence of psoriasis in Norwegian Lapp population. Acta Derm Venereol Suppl (Stockh). 1993;182:6-9.
9. Bell LM, Sedlack R, Beard CM, Perry HO, Michet CJ, Kurland LT. Incidence of psoriasis in Rochester, Minn, 1980-1983. Arch Dermatol. 1991;127(8):1184-1187.
10. Farber EM, Bright RD, Nall ML. Psoriasis: a questionnaire survey of 2,144 patients. Arch Dermatol. 1968;98(3):248-259.
11. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148(1):1-18.
12. Brandrup F, Holm N, Grunnet N, Henningsen K, Hansen HE. Psoriasis in monozygotic twins: variation in expression in individuals with identical genetic constitution. Acta Derm Venereol. 1982;62(3):229-236.
13. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450-456.
14. Könönen M, Torppa J, Lassus A. An epidemiological survey of psoriasis in the greater Helsinki area. Acta Derm Venereol Suppl (Stockh). 1986;124:1-10.
15. Nanda A, Kaur S, Kaur I, Kumar B. Childhood psoriasis: an epidemiologic survey of 112 patients. Pediatr Dermatol. 1990;7(1):19-21.
16. Swanbeck G, Inerot A, Martinsson T, et al. Age at onset and different types of psoriasis. Br J Dermatol. 1995;133(5):768-773.
17. Lindegård B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172(6):298-304.
18. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol. 1988;91(3):197-201.
19. Roth PE, Grosshans E, Bergoend H. Psoriasis: development and fatal complications. Ann Dermatol Venereol. 1991;118(2):97-105.
20. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998;45(5):419-426.
21. Jick H, Jick S, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991;302(6779):766-768.
22. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Saf. 1992;1:347-349.
23. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the General Practice Research Database. Pharmacotherapy. 2003;23(5):686-689.
24. Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol. 2003;139(11):1425- 1429.
25. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537-1541.
26. Gillard SE, Finlay AY. Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care. Int J Clin Pract. 2005;59(11):1260-1267.
27. Basarab T, Munn SE, Jones RR. Diagnostic accuracy and appropriateness of general practitioner referrals to a dermatology out-patient clinic. Br J Dermatol. 1996;135(1):70-73.
28. Kleinbaum DG, Kupper LL, Morgentern H. Epidemiologic Research: Principles and Quantitative Methods. New York, NY: John Wiley & Sons Inc; 1982.
29. Naldi L, Tognoni G, Cainelli T. Analytic epidemiology in psoriasis. J Invest Dermatol. 1994;102(6):19S-23S.
30. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3(2):121-128.
31. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-835.
32. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298(7):321-328. doi:10.1007/s00403- 006-0703-z.
33. Naldi L, Parazzini F, Brevi A, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol. 1992;127(3):212-217.
34. Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol. 1999;135(12):1479-1484.
35. Naldi L, Peli L, Parazzini F, Carrel CF. Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol. 2001;44(3):433-438.
36. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141(12):1527-1534.
37. Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992;128(1):39-42.
38. Horiuchi N, Aiba S, Ozawa H, et al. Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to beta-streptococcal superantigens. Br J Dermatol. 1998;138(2):229-235.
39. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32(6):982-986.
40. Mallbris L, Akre O, Granath F, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004;19(3):225-230.
41. Dika E, Varotti C, Bardazzi F, Maibach HI. Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol. 2006;25(1):1-11.
42. Cohen AD, Bonneh DY, Reuveni H, Vardy DA, Naggan L, Halevy S. Drug exposure and psoriasis vulgaris: case-control and case-crossover studies. Acta Derm Venereol. 2005;85(4):299-303.
43. Cohen AD, Kagen M, Friger M, Halevy S. Calcium channel blockers intake and psoriasis: a case-control study. Acta Derm Venereol. 2001;81(5):347-349.
44. Whittam LR, Wakelin SH, Barker JN. Generalized pustular psoriasis or drug-induced toxic pustuloderma? the use of patch testing. Clin Exp Dermatol. 2000;25(2):122-124.